The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial (Q30833736)

12 August 2017

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial (English)

1 reference

12 August 2017

1 reference

1

Kenneth Rockwood

1 reference

12 August 2017

Sherri Fay

2

1 reference

12 August 2017

Mary Gorman

series ordinal

3

1 reference

12 August 2017

Daniel Carver

series ordinal

4

1 reference

12 August 2017

Janice E Graham

series ordinal

5

1 reference

12 August 2017

30 August 2007

1 reference

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

26

1 reference

Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

An innovative approach to involve patients in measuring treatment effects in drug trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Cholinesterase inhibitors for Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Goal setting and attainment in Alzheimer's disease patients treated with donepezil

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Clinical global impressions in Alzheimer's clinical trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

The Clinical Dementia Rating (CDR): current version and scoring rules

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

A new rating scale for Alzheimer's disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Cornell Scale for Depression in Dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey

21 June 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Verbal repetition in patients with Alzheimer's disease who receive donepezil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Goal attainment scaling: A general method for evaluating comprehensive community mental health programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

Donepezil for severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2377-7-26

A psychometric evaluation of the Cornell Scale for Depression in Dementia in a frail, nursing home population

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

Qualitative analysis of the clinician interview-based impression of change (Plus): methodological issues and implications for clinical research

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034585

A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17760991

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assessing dementia: the Canadian consensus. Organizing Committee, Canadian Consensus Conference on the Assessment of Dementia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17760991

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17760991

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-7-26

1 reference

Dimensions Publication ID

12 August 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-7-26

1 reference

12 August 2017

PubMed publication ID

17760991

1 reference